Anzeige
Mehr »
Freitag, 10.07.2026 - Börsentäglich über 12.000 News
483 Gramm Gold pro Tonne! Diese Gold-Aktie hat zwei Asse im Ärmel
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A112C8 | ISIN: FR0010120402 | Ticker-Symbol: 941
Stuttgart
10.07.26 | 19:01
0,659 Euro
+1,07 % +0,007
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
THERACLION SA Chart 1 Jahr
5-Tage-Chart
THERACLION SA 5-Tage-Chart
RealtimeGeldBriefZeit
0,6450,69719:40

Aktuelle News zur THERACLION Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
DoTheraclion Strengthens Its Governance by Appointing Vincent Gardès as Chairman of Its Board of Directors306Regulatory News: THERACLION (ISIN: FR0010120402; Mnemo: ALTHE), an innovative company developing Sonovein, a robotic platform for non-invasive varicose vein therapy using High-Intensity Focused...
► Artikel lesen
02.07.Theraclion: Monthly Information on the Total Number of Voting Rights and Shares Comprising the Share Capital290Article 223-16 Règlement Général de l'Autorité des marchés financiers Regulatory News: Theraclion (Paris:ALTHE): Listed on Euronext Growth Paris PEA PME eligible ISIN Code: FR0010120402 Website:...
► Artikel lesen
18.06.Theraclion Announces the Evolution of Its Board of Directors782Regulatory News: THERACLION (ISIN: FR0010120402; Mnemo: ALTHE), an innovative company developing Sonovein, a robotic platform for non-invasive varicose vein therapy using High-Intensity Focused...
► Artikel lesen
08.06.Theraclion Secures Key U.S. Reimbursement Milestone for Sonovein With AMA CPT Editorial Panel Approval of a New Category III CPT Code354Regulatory News: Theraclion (ISIN: FR0010120402; Ticker: ALTHE), an innovative company developing a platform for non-invasive therapy using high intensity focused ultrasound (HIFU) for the treatment...
► Artikel lesen
04.06.Theraclion Announces First Clinical Deployment of Sonovein in Hainan, China381Regulatory News: THERACLION (ISIN: FR0010120402 Mnemo: ALTHE), an innovative company developing a robotic platform for non-invasive therapy using high intensity focused ultrasound (HIFU) for the...
► Artikel lesen
03.06.Theraclion: Monthly Information on the Total Number of Voting Rights and Shares Comprising the Share Capital338Article 223-16 du Règlement Général de l'Autorité des marchés financiers Regulatory News: Theraclion (Paris:ALTHE): Listed on Euronext Growth Paris PEA PME eligible ISIN Code: FR0010120402 Website:...
► Artikel lesen
THERACLION Aktie jetzt für 0€ handeln
01.06.Theraclion Announces the Success of the First International HIFU Congress in Parma, Where Promising Preliminary Results From Its Sonovein SpeedPulse Were Presented362Regulatory News: This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260601718811/en/Illustration of Sonovein with new robotics SpeedPulse Theraclion...
► Artikel lesen
11.05.Theraclion Announces the Strong Success of Its Oversubscribed Capital Increase386Capital increase of a gross amount of 6 million Issue of 12,484,467 BSA enabling an additional fundraising of 2 million Regulatory News: This press release and the information it contains...
► Artikel lesen
28.04.Theraclion's non-invasive varicose treatment poised for FDA decision2
23.04.XFRA NEW INSTRUMENTS AVAILABLE ON 23.04.2026442The following instruments on XETRA do have their first trading 23.04.2026 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 23.04.2026 Aktien 1 ID1000132806 PT Multi Bintang Indonesia...
► Artikel lesen
20.04.Theraclion Announces the Launch of a Capital Increase Through the Issuance of ABSA (Shares With Share Warrants Attached), With Preferential Subscription Rights for Existing Shareholders, for a Gross Amount of €6 Million, Secured by Subscription...685Subscription price: €0.48 per share, representing a nominal discount of 3.52% to the closing share price as of April 17, 2026, and a discount of 8.60% when taking into account the theoretical...
► Artikel lesen
16.04.Theraclion Publishes Its 2025 Financial Results and Provides an Update on Its Outlook559Regulatory News: THERACLION (ISIN: FR0010120402; Mnemo: ALTHE), an innovative company developing Sonovein, a robotic platform for non-invasive High-Intensity Focused Ultrasound (HIFU) varicose...
► Artikel lesen
29.01.Theraclion Delivers a Structuring Year in 2025 and Prepares to Scale up458Regulatory News: THERACLION (ISIN: FR0010120402; Mnemo: ALTHE), an innovative company developing Sonovein, a robotic platform for non-invasive High-Intensity Focused Ultrasound (HIFU) varicose...
► Artikel lesen
09.12.25Theraclion Announces Sonovein FDA Submission Following a Strong Year of Regulatory and Clinical Achievements661Regulatory News: THERACLION (ISIN: FR0010120402; Mnemo: ALTHE), an innovative company developing Sonovein, a robotic platform for non-invasive High-Intensity Focused Ultrasound (HIFU) varicose...
► Artikel lesen
29.10.25Theraclion Reports Major Recent Developments and Announces Its 2025 Half-Year Financial Results559Regulatory News: THERACLION (ISIN: FR0010120402; Mnemo: ALTHE), an innovative company developing Sonovein, a robotic platform for non-invasive High-Intensity Focused Ultrasound (HIFU) varicose...
► Artikel lesen
21.10.25Theraclion Secures Key Chinese Certification, Advancing Toward Market Access in China426Regulatory News: THERACLION (ISIN: FR0010120402; Mnemo: ALTHE), an innovative company developing Sonovein®, a robotic platform for non-invasive High-Intensity Focused Ultrasound (HIFU) varicose...
► Artikel lesen
10.10.25Theraclion: Monthly Information on the Total Number of Voting Rights and Shares Comprising the Share Capital493Article 223-16 du Règlement Général de l'Autorité des marchés financiers Regulatory News: Theraclion (Paris:ALTHE): Place de cotation: Euronext Growth Paris Éligible PEA PME Code ISIN:...
► Artikel lesen
24.09.25Theraclion: Sonovein Receives MDR Certification, Strengthening Its Commercial Potential460Regulatory News: THERACLION (ISIN: FR0010120402; Mnemo: ALTHE), an innovative company developing Sonovein®, a robotic platform for non-invasive High-Intensity Focused Ultrasound (HIFU) varicose...
► Artikel lesen
15.09.25Theraclion Announces Successful U.S. FDA Pivotal Study With 96.8% Occlusion Rate432Regulatory News: This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250915148081/en/Sonovein redefines varicose vein treatment with advanced...
► Artikel lesen
25.07.25Theraclion Growth Up in S1 2025845Regulatory News: This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250725366467/en/Sonovein®, the first and only non-invasive varicose veins...
► Artikel lesen
20 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1